Washington University St. Louis School of Medicine: Investigational Drugs Didn't Slow Memory Loss in Rare, Inherited Alzheimer's, Initial Analysis Indicates
February 11, 2020
February 11, 2020
ST. LOUIS, Missouri, Feb. 11 [TNSmedicalresearch] -- The Washington University St. Louis School of Medicine issued the following news release:
Randall J. Bateman, MD, of Washington University School of Medicine in St. Louis, led an international trial evaluating whether investigational drugs could slow memory loss and cognitive decline in a rare, inherited form of Alzheimer's disease. The trial was conducted at 24 sites in Australia, Canada, France, Spain, the United Kingdom and the . . .
Randall J. Bateman, MD, of Washington University School of Medicine in St. Louis, led an international trial evaluating whether investigational drugs could slow memory loss and cognitive decline in a rare, inherited form of Alzheimer's disease. The trial was conducted at 24 sites in Australia, Canada, France, Spain, the United Kingdom and the . . .